-
1
-
-
84937782950
-
Estimated age-standardised incidence and mortality rates: women
-
Globocan: Population fact sheets. Estimated age-standardised incidence and mortality rates: women [ http://globocan.iarc.fr/Pages/fact_sheets_population.aspx ]
-
-
-
-
2
-
-
67650487925
-
Screening for ovarian cancer
-
Clarke-Pearson D. Screening for ovarian cancer. N Engl J Med. 2009;361:170-7.
-
(2009)
N Engl J Med
, vol.361
, pp. 170-177
-
-
Clarke-Pearson, D.1
-
3
-
-
36849051967
-
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer
-
Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem. 2007;102:1117-29.
-
(2007)
J Cell Biochem
, vol.102
, pp. 1117-1129
-
-
Chien, J.R.1
Aletti, G.2
Bell, D.A.3
Keeney, G.L.4
Shridhar, V.5
Hartmann, L.C.6
-
4
-
-
45749108933
-
How do real tumors become resistant to cisplatin?
-
Borst P, Rottenberg S, Jonkers J. How do real tumors become resistant to cisplatin? Cell Cycle. 2008;7:1353-9.
-
(2008)
Cell Cycle
, vol.7
, pp. 1353-1359
-
-
Borst, P.1
Rottenberg, S.2
Jonkers, J.3
-
5
-
-
84876093576
-
DNA damage-induced apoptosis: from specific DNA lesions to the DNA damage response and apoptosis
-
Roos WP, Kaina B. DNA damage-induced apoptosis: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett. 2012;332:237-48.
-
(2012)
Cancer Lett
, vol.332
, pp. 237-248
-
-
Roos, W.P.1
Kaina, B.2
-
6
-
-
12344314253
-
Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells
-
Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, et al. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther. 2004;3:1543-9.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 1543-1549
-
-
Song, I.S.1
Savaraj, N.2
Siddik, Z.H.3
Liu, P.4
Wei, Y.5
Wu, C.J.6
Kuo, M.T.7
-
7
-
-
0026594392
-
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
-
Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A. 1992;1992(89):3070-4.
-
(1992)
Proc Natl Acad Sci U S A
, vol.1992
, Issue.89
, pp. 3070-3074
-
-
Godwin, A.K.1
Meister, A.2
O'Dwyer, P.J.3
Huang, C.S.4
Hamilton, T.C.5
Anderson, M.E.6
-
8
-
-
0025775323
-
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation
-
Parker RJ, Eastman A, Bostick-Bruton F, Reed E. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest. 1991;87:772-7.
-
(1991)
J Clin Invest
, vol.87
, pp. 772-777
-
-
Parker, R.J.1
Eastman, A.2
Bostick-Bruton, F.3
Reed, E.4
-
9
-
-
3242734736
-
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells
-
Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, et al. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res. 2004;10:4661-9.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4661-4669
-
-
Samimi, G.1
Safaei, R.2
Katano, K.3
Holzer, A.K.4
Rochdi, M.5
Tomioka, M.6
Goodman, M.7
Howell, S.B.8
-
10
-
-
4844219967
-
Linking measured intercellular oxygen concentration to human cell functions
-
Ebbesen P, Eckardt KU, Ciampor F, Petterson EO. Linking measured intercellular oxygen concentration to human cell functions. Acta Oncol. 2004;43:598-600.
-
(2004)
Acta Oncol
, vol.43
, pp. 598-600
-
-
Ebbesen, P.1
Eckardt, K.U.2
Ciampor, F.3
Petterson, E.O.4
-
11
-
-
34247527730
-
Hypoxia-inducible factors, stem cells, and cancer
-
Keith B, Simon C. Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007;129:465-72.
-
(2007)
Cell
, vol.129
, pp. 465-472
-
-
Keith, B.1
Simon, C.2
-
12
-
-
44449159236
-
Reactive oxygen species and HIF-1 signalling in cancer
-
Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, Sandaltzopoulos R. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008;266:12-20.
-
(2008)
Cancer Lett
, vol.266
, pp. 12-20
-
-
Galanis, A.1
Pappa, A.2
Giannakakis, A.3
Lanitis, E.4
Dangaj, D.5
Sandaltzopoulos, R.6
-
13
-
-
0037214282
-
Hypoxia-Inducible Factor 1A is essential for cell cycle arrest during hypoxia
-
Goda N, Ryan HE, Khadivi B, McNulty W, Ricert RC, Johnson RS. Hypoxia-Inducible Factor 1A is essential for cell cycle arrest during hypoxia. Mol Cell Biol. 2003;23:359-69.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 359-369
-
-
Goda, N.1
Ryan, H.E.2
Khadivi, B.3
McNulty, W.4
Ricert, R.C.5
Johnson, R.S.6
-
14
-
-
0142166332
-
Targeting HIF-1 for cancer therapy
-
Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721-31.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 721-731
-
-
Semenza, G.L.1
-
15
-
-
70249099280
-
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
-
Selvendiran K, Bratasz A, Kuppusamy ML, Tazi MF, Fivera BK, Kuppusamy P. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer. 2009;125:2198-204.
-
(2009)
Int J Cancer
, vol.125
, pp. 2198-2204
-
-
Selvendiran, K.1
Bratasz, A.2
Kuppusamy, M.L.3
Tazi, M.F.4
Fivera, B.K.5
Kuppusamy, P.6
-
16
-
-
33846558132
-
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells
-
Stoek A, Gast D, Sanderson MP, Issa Y, Gutwein P, Altevogt P. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol. 2007;104:461-9.
-
(2007)
Gynecol Oncol
, vol.104
, pp. 461-469
-
-
Stoek, A.1
Gast, D.2
Sanderson, M.P.3
Issa, Y.4
Gutwein, P.5
Altevogt, P.6
-
17
-
-
0030025773
-
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
-
Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CH, Lowe SW, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88-91.
-
(1996)
Nature
, vol.379
, pp. 88-91
-
-
Graeber, T.G.1
Osmanian, C.2
Jacks, T.3
Housman, D.E.4
Koch, C.H.5
Lowe, S.W.6
Giaccia, A.J.7
-
18
-
-
77952055154
-
HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers
-
Baba Y, Nosho K, Shima K, Irahara N, Chan A, Meyerhardt JA, et al. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol. 2010;176:2292-301.
-
(2010)
Am J Pathol
, vol.176
, pp. 2292-2301
-
-
Baba, Y.1
Nosho, K.2
Shima, K.3
Irahara, N.4
Chan, A.5
Meyerhardt, J.A.6
Chung, D.C.7
Giovannucci, E.L.8
Fuchs, C.S.9
Ogino, S.10
-
19
-
-
79959688925
-
Coexpression of hypoxia-inducible factor -1a and glucose transporter 1 is associated with poor prognosis in oral squamous cell carcinoma patients
-
Eckert A, Lautner M, Schutze A, Taubert H, Schubert J, Bilkenroth U. Coexpression of hypoxia-inducible factor -1a and glucose transporter 1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology. 2011;58:1136-47.
-
(2011)
Histopathology
, vol.58
, pp. 1136-1147
-
-
Eckert, A.1
Lautner, M.2
Schutze, A.3
Taubert, H.4
Schubert, J.5
Bilkenroth, U.6
-
20
-
-
34247155290
-
Hypoxia inducible factor-1a expression as a factor predictive of efficacy of platinum/taxane chemotherapy in advanced primary epithelial ovarian cancer
-
Nakai H, Watanabe Y, Ueda H, Hoshiai H. Hypoxia inducible factor-1a expression as a factor predictive of efficacy of platinum/taxane chemotherapy in advanced primary epithelial ovarian cancer. Cancer Lett. 2007;251:164-7.
-
(2007)
Cancer Lett
, vol.251
, pp. 164-167
-
-
Nakai, H.1
Watanabe, Y.2
Ueda, H.3
Hoshiai, H.4
-
21
-
-
84905992256
-
Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia
-
Olbryt M, Habryka A, Student S, Jarzab M, Tyszkiewicz T, Lisowska KM. Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia. PLoS One. 2014;9, e105104.
-
(2014)
PLoS One
, vol.9
-
-
Olbryt, M.1
Habryka, A.2
Student, S.3
Jarzab, M.4
Tyszkiewicz, T.5
Lisowska, K.M.6
-
22
-
-
84901664492
-
Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma
-
Du J, Sun B, Zhao X, Gu Q, Dong Z, Mo J, et al. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Gynecol Oncol. 2014;133:575-83.
-
(2014)
Gynecol Oncol
, vol.133
, pp. 575-583
-
-
Du, J.1
Sun, B.2
Zhao, X.3
Gu, Q.4
Dong, Z.5
Mo, J.6
Sun, T.7
Wang, J.8
Sun, R.9
Liu, Y.10
-
23
-
-
84925283907
-
The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas
-
Aug 29 [Epub ahead of print].
-
Cheng S, Han L, Guo J, Yang Q Zhou J, Yang X. The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas. Tumour Biol 2014; Aug 29 [Epub ahead of print].
-
(2014)
Tumour Biol
-
-
Cheng, S.1
Han, L.2
Guo, J.3
Yang, Q.4
Zhou, J.5
Yang, X.6
-
24
-
-
0021185050
-
Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches
-
Hamilton TC, Young RC, Ozols RF. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. Semin Oncol. 1984;11:285-98.
-
(1984)
Semin Oncol
, vol.11
, pp. 285-298
-
-
Hamilton, T.C.1
Young, R.C.2
Ozols, R.F.3
-
25
-
-
0023111825
-
Characterization of a cisdiamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
-
Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, et al. Characterization of a cisdiamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 1987;47:414-8.
-
(1987)
Cancer Res
, vol.47
, pp. 414-418
-
-
Behrens, B.C.1
Hamilton, T.C.2
Masuda, H.3
Grotzinger, K.R.4
Whang-Peng, J.5
Louie, K.G.6
Knutsen, T.7
McKoy, W.M.8
Yung, R.C.9
Ozols, R.F.10
-
26
-
-
0023750017
-
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines
-
Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res. 1988;48:5713-6.
-
(1988)
Cancer Res
, vol.48
, pp. 5713-5716
-
-
Masuda, H.1
Ozols, R.F.2
Lai, G.M.3
Fojo, A.4
Rothenberg, M.5
Hamilton, T.C.6
-
27
-
-
84937797756
-
Affymetrix Genechip gene and Exon Array White Paper Collection
-
Affymetrix: Quality Assessment of Exon and Gene Arrays. Affymetrix Genechip gene and Exon Array White Paper Collection [ http://ibis.tau.ac.il/twiki/pub/Bioinformatics/MicroarrayVarda2009/exon_gene_arrays_quality_assessment_whitepaper.pdf ]
-
-
-
-
28
-
-
4544341015
-
Linear models and empirical Bayes methods for assessing differential gene expression in microarray experiments
-
Smyth GK. Linear models and empirical Bayes methods for assessing differential gene expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:3.
-
(2004)
Stat Appl Genet Mol Biol
, vol.3
, pp. 3
-
-
Smyth, G.K.1
-
30
-
-
34147136617
-
Exploration, normalization and genotype calls of high density oligonucleotide SNP array data
-
Carvalho B, Bengtsson H, Speed TP, Irizarry RA. Exploration, normalization and genotype calls of high density oligonucleotide SNP array data. Biostatistics. 2007;8:485-99.
-
(2007)
Biostatistics
, vol.8
, pp. 485-499
-
-
Carvalho, B.1
Bengtsson, H.2
Speed, T.P.3
Irizarry, R.A.4
-
31
-
-
0142121516
-
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
-
Irrizary RA, Hobbs B, Colin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-64.
-
(2003)
Biostatistics
, vol.4
, pp. 249-264
-
-
Irrizary, R.A.1
Hobbs, B.2
Colin, F.3
Beazer-Barclay, Y.D.4
Antonellis, K.J.5
Scherf, U.6
Speed, T.P.7
-
32
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resource
-
da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resource. Nature Protoc. 2009;4:44-57.
-
(2009)
Nature Protoc
, vol.4
, pp. 44-57
-
-
Huang, W.1
Sherman, B.T.2
Lempicki, R.A.3
-
33
-
-
58549112996
-
Bioinformatics Enrichment Tools: paths towards the comprehensive functional analysis of large gene lists
-
da Huang W, Sherman BT, Lempicki RA. Bioinformatics Enrichment Tools: paths towards the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1-13.
-
(2009)
Nucleic Acids Res
, vol.37
, pp. 1-13
-
-
Huang, W.1
Sherman, B.T.2
Lempicki, R.A.3
-
34
-
-
3042786293
-
A gene network for navigating the literature
-
Hoffmann R, Valencia A. A gene network for navigating the literature. Nature Genet. 2004;36:664.
-
(2004)
Nature Genet
, vol.36
, pp. 664
-
-
Hoffmann, R.1
Valencia, A.2
-
35
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402-8.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
36
-
-
84859300048
-
Low dose hyper-radiosensitivity is eliminated during exposure to cycling hypoxia but returns after reoxygenation
-
Edin NJ, Olsen DR, Sandvik JA, Malinen E, Pettersen EO. Low dose hyper-radiosensitivity is eliminated during exposure to cycling hypoxia but returns after reoxygenation. Int J Radiat Biol. 2012;88:311-9.
-
(2012)
Int J Radiat Biol
, vol.88
, pp. 311-319
-
-
Edin, N.J.1
Olsen, D.R.2
Sandvik, J.A.3
Malinen, E.4
Pettersen, E.O.5
-
37
-
-
80054724189
-
Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells
-
Kato Y, Yashiro M, Fuyuhiro Y, Kashiwaqi S, Matsuoka J, Hirakawa T, et al. Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells. Anticancer Res. 2011;31:3369-75.
-
(2011)
Anticancer Res
, vol.31
, pp. 3369-3375
-
-
Kato, Y.1
Yashiro, M.2
Fuyuhiro, Y.3
Kashiwaqi, S.4
Matsuoka, J.5
Hirakawa, T.6
Noda, S.7
Aomatsu, N.8
Hasegawa, T.9
Matsuzaki, T.10
Sawada, T.11
Ohira, M.12
Hirakawa, K.13
-
38
-
-
0026003123
-
Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance
-
Sakata K, Tak Kwok T, Murphy B, Laderoute K, Gordon GR, Sutherland RM. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer. 1991;64:809-14.
-
(1991)
Br J Cancer
, vol.64
, pp. 809-814
-
-
Sakata, K.1
Tak Kwok, T.2
Murphy, B.3
Laderoute, K.4
Gordon, G.R.5
Sutherland, R.M.6
-
39
-
-
84964694424
-
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumour growth delay in the chemoresistant ovarian cancer model A2780cis
-
Meier JC, Haendler B, Seidel H, Groth P, Adams R, Ziegelbauer K, et al. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumour growth delay in the chemoresistant ovarian cancer model A2780cis. Cancer Med. 2015;4:253-67.
-
(2015)
Cancer Med
, vol.4
, pp. 253-267
-
-
Meier, J.C.1
Haendler, B.2
Seidel, H.3
Groth, P.4
Adams, R.5
Ziegelbauer, K.6
Kreft, B.7
Beckmann, G.8
Sommer, A.9
Kopitz, C.10
-
40
-
-
84905055572
-
Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells
-
Schmidt S, Liu G, Liu G, Yang W, Honisch S, Pantelakos S, et al. Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells. Oncotarget. 2014;15:4799-810.
-
(2014)
Oncotarget
, vol.15
, pp. 4799-4810
-
-
Schmidt, S.1
Liu, G.2
Liu, G.3
Yang, W.4
Honisch, S.5
Pantelakos, S.6
Stournaras, C.7
Hönig, A.8
Lang, F.9
-
41
-
-
84868123852
-
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro
-
Hahne JC, Honig A, Meyer SR, Gambaryan S, Walter U, Wischhusen J, et al. Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro. Oncol Rep. 2012;28:2023-8.
-
(2012)
Oncol Rep
, vol.28
, pp. 2023-2028
-
-
Hahne, J.C.1
Honig, A.2
Meyer, S.R.3
Gambaryan, S.4
Walter, U.5
Wischhusen, J.6
Häussler, S.F.7
Segerer, S.E.8
Fujita, N.9
Dietl, J.10
Engel, J.B.11
-
42
-
-
84878843251
-
Contribution of intracellular ATP to cisplatin resistance of tumor cells
-
Schneider V, Krieger ML, Bendas G, Jaehde U, Kalayda GV. Contribution of intracellular ATP to cisplatin resistance of tumor cells. J Biol Inorg Chem. 2013;18:165-74.
-
(2013)
J Biol Inorg Chem
, vol.18
, pp. 165-174
-
-
Schneider, V.1
Krieger, M.L.2
Bendas, G.3
Jaehde, U.4
Kalayda, G.V.5
-
43
-
-
84866499041
-
Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells
-
Kalayda GV, Wagner CH, Jaehde U. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells. J Inorg Biochem. 2012;116:1-10.
-
(2012)
J Inorg Biochem
, vol.116
, pp. 1-10
-
-
Kalayda, G.V.1
Wagner, C.H.2
Jaehde, U.3
-
44
-
-
0036121363
-
p53 regulation of DNA repair pathways
-
Smith ML, Seo YR. p53 regulation of DNA repair pathways. Mutagenesis. 2002;17:149-56.
-
(2002)
Mutagenesis
, vol.17
, pp. 149-156
-
-
Smith, M.L.1
Seo, Y.R.2
-
45
-
-
59249106025
-
Glutathione peroxidise 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell carcinoma
-
Saga Y, Ohwada M, Susuki M, Konno R, Kigawa J, Ueno S, et al. Glutathione peroxidise 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell carcinoma. Oncol Rep. 2008;20:1299-303.
-
(2008)
Oncol Rep
, vol.20
, pp. 1299-1303
-
-
Saga, Y.1
Ohwada, M.2
Susuki, M.3
Konno, R.4
Kigawa, J.5
Ueno, S.6
Mano, H.7
-
46
-
-
73549115639
-
Identification of cisplatin-resistance associated genes in head and neck squamous cell carcinoma
-
Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H, et al. Identification of cisplatin-resistance associated genes in head and neck squamous cell carcinoma. Int J Cancer. 2010;126:437-49.
-
(2010)
Int J Cancer
, vol.126
, pp. 437-449
-
-
Yamano, Y.1
Uzawa, K.2
Saito, K.3
Nakashima, D.4
Kasamatsu, A.5
Koike, H.6
Kouzu, Y.7
Shinozuka, K.8
Nakatani, K.9
Negoro, K.10
Fujita, S.11
Tanzawa, H.12
-
47
-
-
69449103357
-
Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase
-
LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassi EM, Afton SE, Ben-Jonathan N. Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase. Carcinogenesis. 2009;30:1298-304.
-
(2009)
Carcinogenesis
, vol.30
, pp. 1298-1304
-
-
LaPensee, E.W.1
Schwemberger, S.J.2
LaPensee, C.R.3
Bahassi, E.M.4
Afton, S.E.5
Ben-Jonathan, N.6
-
48
-
-
84861345772
-
Hyperactive EGF receptor, Jaks and STAT3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
-
Yue P, Zhang X, Paladino D, Sengupta B, Ahmad S, Holloway RW, et al. Hyperactive EGF receptor, Jaks and STAT3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Oncogene. 2012;31:2309-22.
-
(2012)
Oncogene
, vol.31
, pp. 2309-2322
-
-
Yue, P.1
Zhang, X.2
Paladino, D.3
Sengupta, B.4
Ahmad, S.5
Holloway, R.W.6
Ingersoll, S.B.7
Turkson, J.8
-
49
-
-
21344437105
-
Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma
-
Nakatani K, Wada T, Nakamura M, Uzawa K, Tanzawa H, Fujita S. Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2005;131:445-52.
-
(2005)
J Cancer Res Clin Oncol
, vol.131
, pp. 445-452
-
-
Nakatani, K.1
Wada, T.2
Nakamura, M.3
Uzawa, K.4
Tanzawa, H.5
Fujita, S.6
-
50
-
-
0035011210
-
Caveolin-1 expression in advanced-stage ovarian carcinoma - a clinicopathologic study
-
Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotieb WH, Byrne M, et al. Caveolin-1 expression in advanced-stage ovarian carcinoma - a clinicopathologic study. Gynecol Oncol. 2001;81:166-71.
-
(2001)
Gynecol Oncol
, vol.81
, pp. 166-171
-
-
Davidson, B.1
Nesland, J.M.2
Goldberg, I.3
Kopolovic, J.4
Gotieb, W.H.5
Byrne, M.6
Ben-Baruch, G.7
Berner, A.8
Reich, R.9
-
51
-
-
70450237022
-
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
-
Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 2009;28:4065-7404.
-
(2009)
Oncogene
, vol.28
, pp. 4065-7404
-
-
Song, B.1
Wang, Y.2
Xi, Y.3
Kudo, K.4
Bruheim, S.5
Botchkina, G.I.6
Gavin, E.7
Wan, Y.8
Formentini, A.9
Kornmann, M.10
Fodstad, O.11
Ju, J.12
-
52
-
-
0036338490
-
Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary
-
Itamochi H, Kigaawa K, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol. 2002;100:281-7.
-
(2002)
Obstet Gynecol
, vol.100
, pp. 281-287
-
-
Itamochi, H.1
Kigaawa, K.2
Sugiyama, T.3
Kikuchi, Y.4
Suzuki, M.5
Terakawa, N.6
-
53
-
-
41349083323
-
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
-
Itamochi J, Kigawa K, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99:653-8.
-
(2008)
Cancer Sci
, vol.99
, pp. 653-658
-
-
Itamochi, J.1
Kigawa, K.2
Terakawa, N.3
-
54
-
-
84937805434
-
ASCO Educational book
-
Accessed 15 April 2015
-
Gershenson. 2013. ASCO Educational book. Available at: http://meetinglibrary.asco.org/content/224-132 . Accessed 15 April 2015.
-
(2013)
-
-
-
55
-
-
0031038420
-
Hypoxia-inducible factor-1a is regulated at the post-mRNA level
-
Wenger RH, Kvietikova I, Rolfs A, Gassmann M, Marti HH. Hypoxia-inducible factor-1a is regulated at the post-mRNA level. Kidney Int. 1997;51:560-3.
-
(1997)
Kidney Int
, vol.51
, pp. 560-563
-
-
Wenger, R.H.1
Kvietikova, I.2
Rolfs, A.3
Gassmann, M.4
Marti, H.H.5
-
56
-
-
27744482673
-
Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R
-
Nakamura M, Nakatani K, Uzawa K, Ono K, Uesugi H, Ogawara K, et al. Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R. Oncol Rep. 2005;14:1281-6.
-
(2005)
Oncol Rep
, vol.14
, pp. 1281-1286
-
-
Nakamura, M.1
Nakatani, K.2
Uzawa, K.3
Ono, K.4
Uesugi, H.5
Ogawara, K.6
Shiiba, M.7
Bukawa, H.8
Yokoe, H.9
Wada, T.10
-
57
-
-
33847192750
-
Gene expression profiling of paired ovarian tumours obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumours
-
L'Esperance S, Popa I, Bachvarova M, Plante M, Patten N, Wu L, et al. Gene expression profiling of paired ovarian tumours obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumours. Int J Oncol. 2006;29:5-24.
-
(2006)
Int J Oncol
, vol.29
, pp. 5-24
-
-
L'Esperance, S.1
Popa, I.2
Bachvarova, M.3
Plante, M.4
Patten, N.5
Wu, L.6
Tetu, B.7
Bachvarov, D.8
-
58
-
-
77349109465
-
Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma
-
Gu F, Ma Y, Zhang Z, Zhao J, Kobayashi H, Zhang L, et al. Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncology Rep. 2010;23:671-6.
-
(2010)
Oncology Rep
, vol.23
, pp. 671-676
-
-
Gu, F.1
Ma, Y.2
Zhang, Z.3
Zhao, J.4
Kobayashi, H.5
Zhang, L.6
Fu, L.7
-
59
-
-
79960455637
-
Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in ovarian cancer cell lines
-
Drenzek JG, Seiler NL, Jaskula-Szutl R, Rausch MM, Rose SL. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in ovarian cancer cell lines. Gynecol Oncol. 2011;122:396-401.
-
(2011)
Gynecol Oncol
, vol.122
, pp. 396-401
-
-
Drenzek, J.G.1
Seiler, N.L.2
Jaskula-Szutl, R.3
Rausch, M.M.4
Rose, S.L.5
-
60
-
-
84856729767
-
Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A
-
Zhang X, Samadi AK, Roby KF, Timmermann B, Cohen MS. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol Oncol. 2012;124:606-12.
-
(2012)
Gynecol Oncol
, vol.124
, pp. 606-612
-
-
Zhang, X.1
Samadi, A.K.2
Roby, K.F.3
Timmermann, B.4
Cohen, M.S.5
-
61
-
-
75749137250
-
Expression of angiopoietin-like 4 and tenacin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma
-
Wang Z, Han B, Zhang Z, Pan J, Xia H. Expression of angiopoietin-like 4 and tenacin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma. Biomarkers. 2010;15:39-46.
-
(2010)
Biomarkers
, vol.15
, pp. 39-46
-
-
Wang, Z.1
Han, B.2
Zhang, Z.3
Pan, J.4
Xia, H.5
-
62
-
-
78649633710
-
Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma
-
Shibata K, Nakayama T, Hirakawa H, Hidaka S, Nagayasu T. Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma. J Clin Pathol. 2010;63:1054-8.
-
(2010)
J Clin Pathol
, vol.63
, pp. 1054-1058
-
-
Shibata, K.1
Nakayama, T.2
Hirakawa, H.3
Hidaka, S.4
Nagayasu, T.5
-
63
-
-
84921435963
-
ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma
-
Tanaka J, Irié T, Yamamoto G, Isobe T, Hokazono C, Tachikawa T, et al. ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma. J Oral Pathol Med. 2015;44:126-33.
-
(2015)
J Oral Pathol Med
, vol.44
, pp. 126-133
-
-
Tanaka, J.1
Irié, T.2
Yamamoto, G.3
Isobe, T.4
Hokazono, C.5
Tachikawa, T.6
Kohno, Y.7
Mishima, K.8
-
64
-
-
84881012134
-
Clinical significance of angiopoietin-like 4 expression in tissue and the serum of esophageal squamous cell carcinoma patients
-
Yi J, Pan BZ, Xiong L, Song HZ. Clinical significance of angiopoietin-like 4 expression in tissue and the serum of esophageal squamous cell carcinoma patients. Med Oncol. 2013;30:680.
-
(2013)
Med Oncol
, vol.30
, pp. 680
-
-
Yi, J.1
Pan, B.Z.2
Xiong, L.3
Song, H.Z.4
-
65
-
-
84886736125
-
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
-
Khong TL, Thairu N, Larsen H, Dawson PM, Kiriakidis S, Paleolog EM. Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer. BMC Cancer. 2013;13:518.
-
(2013)
BMC Cancer
, vol.13
, pp. 518
-
-
Khong, T.L.1
Thairu, N.2
Larsen, H.3
Dawson, P.M.4
Kiriakidis, S.5
Paleolog, E.M.6
-
66
-
-
57349172709
-
Chemoresistant cell lines display altered epidermal growth factor receptor and HER3 signaling and senstivity to gefitinib
-
Servidei T, Riccardi A, Mozzetti S, Ferlini C, Riccardi R. Chemoresistant cell lines display altered epidermal growth factor receptor and HER3 signaling and senstivity to gefitinib. Int J Cancer. 2008;123:2939-49.
-
(2008)
Int J Cancer
, vol.123
, pp. 2939-2949
-
-
Servidei, T.1
Riccardi, A.2
Mozzetti, S.3
Ferlini, C.4
Riccardi, R.5
-
67
-
-
70349487546
-
Modulation of HER3 is a marker of dynamic cell signalling in ovarian cancer: implications for pertuzumab sensitivity
-
Nagumo Y, Faratian D, Mullin P, Harrison DJ, Hasmann M, Langdon SP. Modulation of HER3 is a marker of dynamic cell signalling in ovarian cancer: implications for pertuzumab sensitivity. Mol Cancer Res. 2009;7:1563-71.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1563-1571
-
-
Nagumo, Y.1
Faratian, D.2
Mullin, P.3
Harrison, D.J.4
Hasmann, M.5
Langdon, S.P.6
-
68
-
-
84895776236
-
Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by the PI3K/AKT signalling pathway
-
Wu X, Chen Y, Li G, Xia L, Gu R, Wen X, et al. Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by the PI3K/AKT signalling pathway. Med Oncol. 2014;31:903.
-
(2014)
Med Oncol
, vol.31
, pp. 903
-
-
Wu, X.1
Chen, Y.2
Li, G.3
Xia, L.4
Gu, R.5
Wen, X.6
Ming, X.7
Chen, H.8
-
69
-
-
0034654426
-
Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis
-
Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm CS, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J. 2000;346(Pt 3):603-10.
-
(2000)
Biochem J
, vol.346
, pp. 603-610
-
-
Kim, I.1
Kim, H.G.2
Kim, H.3
Kim, H.H.4
Park, S.K.5
Uhm, C.S.6
Lee, Z.H.7
Koh, G.Y.8
-
70
-
-
0037406906
-
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma
-
Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162:1521-8.
-
(2003)
Am J Pathol
, vol.162
, pp. 1521-1528
-
-
Jan, S.1
Amy, C.2
Cazes, A.3
Monnot, C.4
Lamande, N.5
Favier, J.6
Philippe, J.7
Sibony, M.8
Gasc, J.M.9
Corvol, P.10
Germain, S.11
-
71
-
-
0142188732
-
Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4
-
Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, et al. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res. 2003;63:6651-7.
-
(2003)
Cancer Res
, vol.63
, pp. 6651-6657
-
-
Ito, Y.1
Oike, Y.2
Yasunaga, K.3
Hamada, K.4
Miyata, K.5
Matsumoto, S.6
Sugano, S.7
Tanihara, H.8
Masuho, Y.9
Suda, T.10
-
72
-
-
41149157649
-
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4
-
Pauda D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133:66-77.
-
(2008)
Cell
, vol.133
, pp. 66-77
-
-
Pauda, D.1
Zhang, X.H.2
Wang, Q.3
Nadal, C.4
Gerald, W.L.5
Gomis, R.R.6
Massaque, J.7
-
73
-
-
52649160344
-
EGFR family: structure physiology signalling and therapeutic targets
-
Burgess AW. EGFR family: structure physiology signalling and therapeutic targets. Growth Factors. 2008;26:263-74.
-
(2008)
Growth Factors
, vol.26
, pp. 263-274
-
-
Burgess, A.W.1
-
74
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007;316:1039-43.
-
(2007)
Science
, vol.316
, pp. 1039-1043
-
-
Engelman, J.A.1
Zejnullahu, K.2
Mitsudomi, T.3
Song, Y.4
Hyland, C.5
Park, J.O.6
Lindeman, N.7
Gale, C.M.8
Zhao, X.9
Christensen, J.10
Kosaka, T.11
Holmes, A.J.12
Rogers, A.M.13
Cappuzzo, F.14
Mok, T.15
Lee, C.16
Johnson, B.E.17
Cantley, L.C.18
Janne, P.A.19
-
75
-
-
77954958218
-
Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via up-regulation of survivin
-
Wang S, Huang X, Lee C, Liu B. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via up-regulation of survivin. Oncogene. 2010;29:4225-36.
-
(2010)
Oncogene
, vol.29
, pp. 4225-4236
-
-
Wang, S.1
Huang, X.2
Lee, C.3
Liu, B.4
-
76
-
-
84860668033
-
The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination
-
Balz LM, Bartkowiak K, Andreas A, Pantel K, Niggemann B, Zanker KS, et al. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination. J Pathol. 2012;227:234-44.
-
(2012)
J Pathol
, vol.227
, pp. 234-244
-
-
Balz, L.M.1
Bartkowiak, K.2
Andreas, A.3
Pantel, K.4
Niggemann, B.5
Zanker, K.S.6
Brandt, B.H.7
Dittmar, T.8
-
77
-
-
84875048399
-
HER3 overexpression and survival in solid tumors: a meta-analysis
-
Ocana A, Vera-Badillo F, Seruga B, Templeton A, Pandiella A, Amir E. HER3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst. 2013;105:266-73.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 266-273
-
-
Ocana, A.1
Vera-Badillo, F.2
Seruga, B.3
Templeton, A.4
Pandiella, A.5
Amir, E.6
-
78
-
-
84889570568
-
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
-
Huang RYJ, Wong MK, Tan TZ, Kuay KT, Ng AHC, Chung VY, et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis. 2013;4, e915.
-
(2013)
Cell Death Dis
, vol.4
-
-
Huang, R.Y.J.1
Wong, M.K.2
Tan, T.Z.3
Kuay, K.T.4
Ng, A.H.C.5
Chung, V.Y.6
Chu, Y.S.7
Matsumura, N.8
Lai, H.C.9
Lee, Y.F.10
Sim, W.J.11
Chai, C.12
Pietschmann, E.13
Mori, S.14
Low, J.J.H.15
Choolani, M.16
Thiery, J.P.17
-
79
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883-92.
-
(2012)
N Engl J Med
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
Larkin, J.4
Endesfelder, D.5
Gronroos, E.6
Martinez, P.7
Matthews, N.8
Stewart, A.9
Tarpey, P.10
Varela, I.11
Phillimore, B.12
Begum, S.13
McDonald, N.Q.14
Butler, A.15
Jones, D.16
Raine, K.17
Latimer, C.18
Santos, C.R.19
Nohadani, M.20
Eklund, A.C.21
Spencer-Dene, B.22
Clark, G.23
Pickering, L.24
Stamp, G.25
Gore, M.26
Szallasi, Z.27
Downward, J.28
Futreal, P.A.29
Swanton, C.30
more..
-
80
-
-
77951668551
-
Downregulation of epidermal growth factor expression contributes to alpha-TEA's proapoptotic effects in human ovarian cancer cell lines
-
Shun MC, Yu W, Park SK, Sanders BG, Kline K. Downregulation of epidermal growth factor expression contributes to alpha-TEA's proapoptotic effects in human ovarian cancer cell lines. J Oncol. 2010;2010:824571.
-
(2010)
J Oncol
, vol.2010
, pp. 824571
-
-
Shun, M.C.1
Yu, W.2
Park, S.K.3
Sanders, B.G.4
Kline, K.5
|